AI4Eyes Closes $6.5M CAD in Funding to Advance AI-Driven Eye Care Innovation

Insider Brief

  • AI4Eyes secured $6.5 million CAD in new capital during Q4 2025, combining a $3.7 million CAD internal financing round with $2.8 million CAD in non-dilutive funding.
  • The funding supports the company’s transition toward commercialization of regulated, AI-powered eye care solutions and strengthens its balance sheet.
  • Proceeds will accelerate regulatory approvals, expand clinical programs and data collection, advance product development, and support global commercialization efforts.

PRESS RELEASE — AI4Eyes announced the successful closing of a $3.7 million CAD internal financing round from existing investors, completed in Q4 2025, together with $2.8 million CAD in non-dilutive funding. The combined financings bring total new capital secured during the period to $6.5 million CAD.

The funding strengthens AI4Eyes’ balance sheet and supports the company’s next phase of growth as it advances its roadmap toward the commercialization of regulated, AI-powered eye care solutions.

“This financing marks a pivotal milestone for AI4Eyes as we shift into full-scale execution and commercialization” said Dr. Tara Akhavan, CEO of AI4Eyes. “With the continued support of our existing investors and access to non-dilutive funding, we are accelerating regulatory approvals, expand our clinical programs, and bring meaningful AI-driven innovation to eye care providers and patients globally.”

Proceeds from the financing will be used to accelerate regulatory approval activities in Canada and the United States, advance product development, expand data collection and clinical trials, and support commercialization readiness and strategic partnerships across key global markets, including the onboarding of a global expert leadership team.

For more information about AI4Eyes, please visit www.aiforeyes.com or follow the company on LinkedIn at https://www.linkedin.com/company/ai4eyes.

Media Contact: Vanessa Poulin, Head of Product, vanessa.poulin@aiforeyes.com, 418–573–9578; Investor Contact: Dr. Tara Akhavan, CEO, tara.akhavan@aiforeyes.com

SOURCE

Need Deeper Intelligence on the AI Market?

AI Insider's Market Intelligence platform tracks funding rounds, competitive landscapes, and technology trends across the global AI ecosystem in real time. Get the data and insights your organization needs to make informed decisions.

Related Articles

a computer chip in the shape of a human head
Google DeepMind Maps Four Routes From Human-Level AI to Superintelligence

Insider Brief A team of Google DeepMind researchers has laid out four ways that human-level artificial intelligence could push beyond people into superintelligence, and cautioned

Researchers Find Users Trust AI and Human Fact-Checkers Equally, But for Different Reasons

Insider Brief Researchers at Penn State have found that people trust AI-powered fact-checking systems about as much as human fact-checkers. It’s the reasons that are

a computer circuit board with a brain on it
The 20 AI Healthcare & Clinical CEOs You Need to Know in 2026

The transformation of healthcare through artificial intelligence is no longer a speculative proposition. It is happening at scale, in hospitals, in living rooms, in clinical

Stay Updated with AI Insider

Get the latest AI funding news, market intelligence, and industry insights delivered to your inbox weekly.

$ 0 M

Seed round tracked

Gitar — Code Validation

Get the Weekly Briefing

Funding analysis, market intelligence, and industry trends delivered to your inbox every week.

Need bespoke intelligence?

Our team combines real-time data with decades of sector experience to guide your decisions.

Subscribe today for the latest news about the AI landscape